Wei, Yu-Feng

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Ahn, M.-J., Tanaka, K., Paz-Ares, L., Cornelissen, R., Girard, N., Pons-Tostivint, E., Vicente Baz, D., Sugawara, S., Cobo, M., Pérol, M., et al. (2025) · Journal of Clinical Oncology

Lung Cancer Treatments and MutationsLung Cancer Research Studies

Cited by 244

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

Yang, J. C.-H., Shepherd, F. A., Kim, D.-W., Lee, G.-W., Lee, J. S., Chang, G.-C., Lee, S. S., Wei, Y.-F., Lee, Y. G., Laus, G., et al. (2019) · Journal of Thoracic Oncology

Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers

Cited by 210

Safety and treatment completion of latent tuberculosis infection treatment in the elderly population—a prospective observational study in Taiwan

Feng, J.-Y., Huang, W.-C., Lin, S.-M., Wang, T.-Y., Lee, S. S.-J., Shu, C.-C., Pan, S.-W., Chen, C.-Y., Lin, C.-B., Wei, Y.-F., et al. (2020) · International Journal of Infectious Diseases

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 24